SCHEMBL6564232

SCHEMBL6564232

O=C(O)c1cc(S(=O)(=O)c2ccccc2)ccc1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DTYMK P23919 1/20 0.54
KMT2A Q03164 4/20 0.53
POLB P06746 2/20 0.50
KIF18A Q8NI77 1/20 0.49
ABCC9 O60706 1/20 0.48
ABCC8 Q09428 1/20 0.48
KCNJ11 Q14654 1/20 0.48
KCNJ8 Q15842 1/20 0.48
SLC16A1 P53985 1/20 0.48
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47
MEN1 O00255 2/20 0.47
RAB9A P51151 2/20 0.47
VCAM1 P19320 1/20 0.46
SLC25A1 P53007 1/20 0.46
S1PR4 O95977 1/20 0.45
MAPT P10636 1/20 0.45
S1PR1 P21453 1/20 0.45
MAPK1 P28482 1/20 0.45
GFER P55789 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL589336 0.88 KMT2A (0.50) DTYMKKMT2APOLBKIF18AABCC9
SCHEMBL8625649 0.82 ABCC9 (0.45) KMT2APOLBKIF18AABCC9ABCC8
SCHEMBL7322857 0.82 DTYMK (0.58) DTYMKKMT2APOLBGAAMEN1
SCHEMBL2903871 0.81 KMT2A (0.56) KMT2APOLBKIF18AABCC9ABCC8
SCHEMBL1625062 0.81 DTYMK (0.57) DTYMKKMT2APOLBMEN1SLC25A1
SCHEMBL28969126 0.81 DTYMK (0.57) DTYMKKMT2APOLBGAAMEN1
SCHEMBL11030600 0.81 DTYMK (0.57) DTYMKKMT2APOLBMEN1SLC25A1
SCHEMBL5426543 0.80 APEX1 (0.64) KMT2APOLBSLC16A1MEN1MAPT
SCHEMBL29435082 0.80 APEX1 (0.64) KMT2APOLBSLC16A1MEN1MAPT
SCHEMBL1296081 0.80 APEX1 (0.64) KMT2APOLBSLC16A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0765871-B1 Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors FIBROGEN INC (US) 2004-03-31 EP disclosed
CN-1120157-C Substituted quinoline-2-carboxamides, process for their preparation and their use as pharmaceuticals, and intermediates thereof FIBER GENE CORP (US) 2003-09-03 CN disclosed
CN-1282737-A Intermediate product used for preparing substituted quinoline-2-formamide MOECHST AG (DE) 2001-02-07 CN disclosed
EP-0625511-B1 Heterocyclic compounds and their use in pharmaceutical ZENECA LTD (GB) 1999-02-17 EP disclosed
US-5726305-A Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-10 US disclosed
US-5719164-A Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1998-02-17 US disclosed
CN-1154365-A Substituted quinoline-2-carboxamides, process for their preparation and their use as pharmaceuticals, and intermediates thereof HOECHST AG (DE) 1997-07-16 CN disclosed
EP-0765871-A1 Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors HOECHST AKTIENGESELLSCHAFT (DE) 1997-04-02 EP disclosed
US-5504089-A TREATING URINARY INCONTINENCE ZENECA LIMITED (GB) 1996-04-02 US disclosed
EP-0625511-A1 Heterocyclic compounds and their use in pharmaceutical ZENECA LIMITED (GB) 1994-11-23 EP disclosed